Intra-thoracic fat, cardiometabolic risk factors, and subclinical cardiovascular disease in healthy, recently menopausal women screened for the Kronos Early Estrogen Prevention Study (KEEPS).

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMC 3288598)

Published in Atherosclerosis on December 09, 2011

Authors

Gary Huang1, Dan Wang, Irfan Zeb, Matthew J Budoff, S Mitchell Harman, Virginia Miller, Eliot A Brinton, Samar R El Khoudary, JoAnn E Manson, MaryFran R Sowers, Howard N Hodis, George R Merriam, Marcelle I Cedars, Hugh S Taylor, Frederick Naftolin, Rogerio A Lobo, Nanette Santoro, Rachel P Wildman

Author Affiliations

1: Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, United States.

Associated clinical trials:

Kronos Early Estrogen Prevention Study (KEEPS) | NCT00154180

Articles citing this

Multiple adipose depots increase cardiovascular risk via local and systemic effects. Curr Atheroscler Rep (2013) 0.87

Human mediastinal adipose tissue displays certain characteristics of brown fat. Nutr Diabetes (2013) 0.86

Associations of pericardial and intrathoracic fat with coronary calcium presence and progression in a multiethnic study. Obesity (Silver Spring) (2013) 0.85

Adipose tissue and vascular inflammation in coronary artery disease. World J Cardiol (2014) 0.84

Cardiovascular Fat, Menopause, and Sex Hormones in Women: The SWAN Cardiovascular Fat Ancillary Study. J Clin Endocrinol Metab (2015) 0.80

Ectopic fat and adipokines in metabolically benign overweight/obese women: the Kronos Early Estrogen Prevention Study. Obesity (Silver Spring) (2013) 0.79

A prospective study of epicardial adipose tissue and incident metabolic syndrome: the ARIRANG study. J Korean Med Sci (2013) 0.77

Women's Health Initiative Hormone Therapy Trials: New insights on Cardiovascular Disease from Additional Years of Follow up. Curr Cardiovasc Risk Rep (2013) 0.76

Epicardial fat tissue thickness in preeclamptic and normal pregnancies. ISRN Obstet Gynecol (2012) 0.75

Relation of coronary collateral circulation with epicardial fat volume in patients with stable coronary artery disease. J Geriatr Cardiol (2013) 0.75

Correlation between the severity of coronary artery lesions and levels of estrogen, hs-CRP and MMP-9. Exp Ther Med (2014) 0.75

Differential impacts of cardiac and abdominal ectopic fat deposits on cardiometabolic risk stratification. BMC Cardiovasc Disord (2016) 0.75

Postmenopausal Women With Greater Paracardial Fat Have More Coronary Artery Calcification Than Premenopausal Women: The Study of Women's Health Across the Nation (SWAN) Cardiovascular Fat Ancillary Study. J Am Heart Assoc (2017) 0.75

Articles cited by this

Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95

Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54

Nonalcoholic fatty liver disease and risk of future cardiovascular events among type 2 diabetic patients. Diabetes (2005) 3.36

Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis (2006) 2.95

The association of pericardial fat with calcified coronary plaque. Obesity (Silver Spring) (2008) 2.93

Nonalcoholic fatty liver disease is a novel predictor of cardiovascular disease. World J Gastroenterol (2007) 2.71

Improved common carotid elasticity and intima-media thickness measurements from computer analysis of sequential ultrasound frames. Atherosclerosis (2001) 2.70

Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. Circulation (2004) 2.67

Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms. Diabetologia (2005) 2.67

Pericardial fat accumulation in men as a risk factor for coronary artery disease. Atherosclerosis (2001) 2.66

Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J (2007) 2.60

The association of pericardial fat with incident coronary heart disease: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr (2009) 2.53

Pericardial fat burden on ECG-gated noncontrast CT in asymptomatic patients who subsequently experience adverse cardiovascular events. JACC Cardiovasc Imaging (2010) 2.37

Periadventitial fat releases a vascular relaxing factor. FASEB J (2002) 2.29

Relationship of epicardial adipose tissue by echocardiography to coronary artery disease. Heart (2008) 2.19

Echocardiographic epicardial fat: a review of research and clinical applications. J Am Soc Echocardiogr (2009) 2.00

Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severity. J Clin Endocrinol Metab (2005) 1.73

Epicardial fat: properties, function and relationship to obesity. Obes Rev (2007) 1.58

Comparison of usefulness of body mass index versus metabolic risk factors in predicting 10-year risk of cardiovascular events in women. Am J Cardiol (2007) 1.52

Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Endocrinol (Oxf) (2008) 1.45

Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging (2010) 1.25

Increased epicardial fat volume quantified by 64-multidetector computed tomography is associated with coronary atherosclerosis and totally occlusive lesions. Circ J (2009) 1.22

Association between nonalcoholic fatty liver disease and carotid intima-media thickness according to the presence of metabolic syndrome. Atherosclerosis (2008) 1.19

Cardiovascular disease risk of abdominal obesity vs. metabolic abnormalities. Obesity (Silver Spring) (2010) 1.18

Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med (2012) 1.14

Increased epicardial, pericardial, and subcutaneous adipose tissue is associated with the presence and severity of coronary artery calcium. Acad Radiol (2010) 1.07

Association between carotid intima-media thickness and pericardial fat in the Multi-Ethnic Study of Atherosclerosis (MESA). J Stroke Cerebrovasc Dis (2010) 1.00

Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr (2011) 0.97

Epicardial adipose tissue, hepatic steatosis and obesity. J Endocrinol Invest (2007) 0.86

Articles by these authors

(truncated to the top 100)

The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab (2010) 13.29

Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 12.44

Calcium plus vitamin D supplementation and the risk of fractures. N Engl J Med (2006) 12.09

Major causes of death among men and women in China. N Engl J Med (2005) 11.80

Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA (2004) 11.69

Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA (2007) 10.50

Television watching and other sedentary behaviors in relation to risk of obesity and type 2 diabetes mellitus in women. JAMA (2003) 10.05

The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004). Arch Intern Med (2008) 9.95

A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med (2003) 9.24

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial. JAMA (2005) 9.03

Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73

Adiposity as compared with physical activity in predicting mortality among women. N Engl J Med (2004) 8.63

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2010) 7.54

A prospective study of self-reported sleep duration and incident diabetes in women. Diabetes Care (2003) 7.40

Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med (2002) 7.32

Assessment of coronary artery disease by cardiac computed tomography: a scientific statement from the American Heart Association Committee on Cardiovascular Imaging and Intervention, Council on Cardiovascular Radiology and Intervention, and Committee on Cardiac Imaging, Council on Clinical Cardiology. Circulation (2006) 7.16

Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA (2010) 7.12

Diagnostic accuracy of fractional flow reserve from anatomic CT angiography. JAMA (2012) 6.96

Calcium/vitamin D supplementation and cardiovascular events. Circulation (2007) 6.63

Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation (2003) 6.62

Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA (2006) 6.51

Body-mass index and mortality among adults with incident type 2 diabetes. N Engl J Med (2014) 6.51

Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: Meta-analysis of 8 randomized trials involving 37 485 individuals. Arch Intern Med (2010) 6.48

Ambient air pollution and atherosclerosis in Los Angeles. Environ Health Perspect (2005) 6.19

Sex hormone-binding globulin and risk of type 2 diabetes in women and men. N Engl J Med (2009) 6.16

Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. Diabetes (2002) 6.05

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. JAMA (2008) 5.92

Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med (2004) 5.86

Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med (2008) 5.86

Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA (2006) 5.75

Coffee consumption and risk for type 2 diabetes mellitus. Ann Intern Med (2004) 5.67

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography) developed in collaboration with the Society of Atherosclerosis Imaging and Prevention and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol (2007) 5.40

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial. Lancet (2009) 5.22

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Systematic review: Vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med (2010) 5.05

Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. J Clin Epidemiol (2008) 5.05

Physical activity, including walking, and cognitive function in older women. JAMA (2004) 4.90

The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet (2012) 4.87

Effects of estrogen plus progestin on health-related quality of life. N Engl J Med (2003) 4.83

Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med (2009) 4.80

Red meat consumption and mortality: results from 2 prospective cohort studies. Arch Intern Med (2012) 4.72

Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes (2004) 4.67

ACCF/AHA 2007 clinical expert consensus document on coronary artery calcium scoring by computed tomography in global cardiovascular risk assessment and in evaluation of patients with chest pain: a report of the American College of Cardiology Foundation Clinical Expert Consensus Task Force (ACCF/AHA Writing Committee to Update the 2000 Expert Consensus Document on Electron Beam Computed Tomography). Circulation (2007) 4.66

SCCT guidelines for the interpretation and reporting of coronary computed tomographic angiography. J Cardiovasc Comput Tomogr (2009) 4.66

Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies. Lancet (2012) 4.63

2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation (2010) 4.56

Safety of anacetrapib in patients with or at high risk for coronary heart disease. N Engl J Med (2010) 4.42

Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin. JAMA (2008) 4.42

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

Glycemic index, glycemic load, and dietary fiber intake and incidence of type 2 diabetes in younger and middle-aged women. Am J Clin Nutr (2004) 4.29

Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med (2011) 4.28

Dietary patterns, meat intake, and the risk of type 2 diabetes in women. Arch Intern Med (2004) 4.27

Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women: the Women's Health Initiative Observational Study. Arch Intern Med (2005) 4.24

An analysis of calibration and discrimination among multiple cardiovascular risk scores in a modern multiethnic cohort. Ann Intern Med (2015) 4.18

Low-carbohydrate-diet score and the risk of coronary heart disease in women. N Engl J Med (2006) 4.16

Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study. Lancet (2011) 4.06

Body iron stores in relation to risk of type 2 diabetes in apparently healthy women. JAMA (2004) 4.04

Trends in blood pressure among children and adolescents. JAMA (2004) 4.03

Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA (2003) 4.03

Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol (2011) 3.99

Sweetened beverage consumption and risk of coronary heart disease in women. Am J Clin Nutr (2009) 3.90

Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85

Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA (2011) 3.85

From vulnerable plaque to vulnerable patient--Part III: Executive summary of the Screening for Heart Attack Prevention and Education (SHAPE) Task Force report. Am J Cardiol (2006) 3.82

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst (2008) 3.73

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA (2004) 3.69

Nut and peanut butter consumption and risk of type 2 diabetes in women. JAMA (2002) 3.68

Bidirectional association between depression and type 2 diabetes mellitus in women. Arch Intern Med (2010) 3.66

Low CD4+ T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS (2008) 3.66

Major dietary protein sources and risk of coronary heart disease in women. Circulation (2010) 3.65

Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr (2004) 3.61

Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA (2002) 3.60

Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med (2014) 3.57

Conjugated equine oestrogen and breast cancer incidence and mortality in postmenopausal women with hysterectomy: extended follow-up of the Women's Health Initiative randomised placebo-controlled trial. Lancet Oncol (2012) 3.56

Understanding the divergent data on postmenopausal hormone therapy. N Engl J Med (2003) 3.55

The expanding medical and behavioral resources with access to care for everyone health plan. Ann Intern Med (2009) 3.53

Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med (2010) 3.53

Fish and long-chain omega-3 fatty acid intake and risk of coronary heart disease and total mortality in diabetic women. Circulation (2003) 3.50

Mediterranean diet and incidence of and mortality from coronary heart disease and stroke in women. Circulation (2009) 3.47

Diabetes, metformin, and breast cancer in postmenopausal women. J Clin Oncol (2012) 3.47

Prospective study of sudden cardiac death among women in the United States. Circulation (2003) 3.45

Obesity as compared with physical activity in predicting risk of coronary heart disease in women. Circulation (2006) 3.39

T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis (2011) 3.38

A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med (2007) 3.37

Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial. JAMA (2002) 3.36

Primary prevention of stroke by healthy lifestyle. Circulation (2008) 3.32

Relationship of physical activity vs body mass index with type 2 diabetes in women. JAMA (2004) 3.31

Red meat consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. Am J Clin Nutr (2011) 3.27

Coronary artery calcification and mortality in diabetic patients with proteinuria. Kidney Int (2010) 3.23

Diagnostic and prognostic value of absence of coronary artery calcification. JACC Cardiovasc Imaging (2009) 3.23

Optimism, cynical hostility, and incident coronary heart disease and mortality in the Women's Health Initiative. Circulation (2009) 3.09

Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure. AIDS (2005) 3.07

Changes in red meat consumption and subsequent risk of type 2 diabetes mellitus: three cohorts of US men and women. JAMA Intern Med (2013) 3.06

Bone mineral density changes during the menopause transition in a multiethnic cohort of women. J Clin Endocrinol Metab (2007) 3.05

Genetic associations with valvular calcification and aortic stenosis. N Engl J Med (2013) 3.02

Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative observational study. JAMA (2002) 3.01

Sex-hormone-binding globulin and the free androgen index are related to cardiovascular risk factors in multiethnic premenopausal and perimenopausal women enrolled in the Study of Women Across the Nation (SWAN). Circulation (2005) 3.01

Effects of growth hormone–releasing hormone on cognitive function in adults with mild cognitive impairment and healthy older adults: results of a controlled trial. Arch Neurol (2012) 3.01